Insert nameHHS Hospital and Health Service pandemic influenza mass vaccination guideliness

Insert subtitle here (optional)

Insert date2014

Insert name Hospital and Health Service pandemic influenza mass vaccination guidelines – / - 1 -
HHS Hospital and Health Service pandemic influenza mass vaccination guidelines
Published by the State of Queensland (Queensland Health), April May, 2014

This document is licensed under a Creative Commons Attribution 3.0 Australia licence. To view a copy of this licence, visit creativecommons.org/licenses/by/3.0/au
© State of Queensland (Queensland Health) 2014
You are free to copy, communicate and adapt the work, as long as you attribute the State of Queensland (Queensland Health).
For more information contact:
Chief Health Officer Branch/Clinical Innovation Division/Communicable Diseases Unit, Department of Health, GPO Box 2368, Fortitude Valley BC, QLD 4006, email , phone 33289724 or 33289728.Communicable Diseases Unit, Department of Health, GPO Box 48, Brisbane QLD 4001, email , phone 3328 9728
An electronic version of this document is available at
Disclaimer:
The content presented in this publicationis distributed by the Queensland Government as an information source only. The State of Queensland makes no statements, representations or warranties about the accuracy, completeness or reliability of any information contained in this publication. The State of Queensland disclaims all responsibility and all liability (including without limitation for liability in negligence) for all expenses, losses, damages and costs you might incur as a result of the information being inaccurate or incomplete in any way, and for any reason reliance was placed on such information.

Contents

1.Introduction

1.1Review

1.2Approval and implementation

1.3Purpose

1.4Scope

1.5Supporting documents

1.6Objectives

1.7Assumptions

1.8Activation

2.Command, control and coordination

2.1Management within a mass vaccination clinic

2.2Roles and responsibilities

3.Concept of operations

3.1Site selection

Primary mass vaccination clinic

Additional mass vaccination clinics

3.2At risk groups

Aboriginal and Torres Strait Islander peoples

Staff vaccination

3.3Support to non-Queensland Health vaccine service providers

3.4Human resources

Training

3.5Vaccine

Administration of vaccine

Cold chain

Multidose vials

Estimate of amount of vaccine required

Adverse events following immunisation

3.6Monitoring strategy

References

1.Introduction...... 1

1.1Purpose...... 1

1.2Scope...... 1

1.3Supporting documents...... 1

Authorising Policy and Standard/s:...... 1

Procedures, Guidelines and Protocols:...... 1

1.4Related documents...... 1

1.5Objectives...... 2

1.6Assumptions...... 2

2.Command, control and coordination...... 2

Activation...... 3

Management within a mass vaccination clinic...... 3

2.1Roles and responsibilities...... 3

Queensland Health Immunisation Program’s (QHIP) roles and responsibilities are 3

HHS roles and responsibilities are to...... 3

3.Concept of operations...... 4

3.1Site selection...... 4

HHS primary mass vaccination clinic...... 4

High risk groups...... 4

Aboriginal and Torres Strait Islander peoples...... 5

Staff vaccination...... 5

Support to non-Queensland health vaccine service providers...... 5

3.2Human resources...... 5

3.3Training...... 6

3.4Vaccine...... 6

Administration of vaccine...... 6

Cold chain...... 6

Multi-dose vials...... 6

Estimate of amount of vaccine required...... 6

Adverse events following immunisation...... 7

3.5Monitoring strategy...... 7

4.Review...... 7

5.Definitions of terms used in the policy and supporting documents...... 7

6.Approval and implementation...... 8

References...... 11

Insert name HHS pandemic influenza mass vaccination guidelinesInsert name HHS Hospital and Health Service pandemic influenza mass vaccination guideliness – Insert subtitle here (optional) / - 1 -
  1. Introduction

1.1Review

This guideline is due for review on: DD-MM-YYYY

Date of last review: DD-MM-YYYY

Supersedes: insert the name of the superseded guideline

Business area contact insert the name of the business area contact

1.2Approval and implementation

Policy custodian: insert the position of the officer (SO or above) who will have responsibility for implementation of the document

Responsible executive team member: insert the position of the executive management team member responsible for authorising implementation of the document

Approving officer: include name and position of officer approving the document

Approval date: DD-MM-YYYY

Effective from: DD-MM-YYYY

Version Control:

Version / Date / Prepared by / Comments
Insert details of any changes made to this document

1.11.3Purpose

This guideline describes how insert name insert name HHS will establish and manage a mass vaccination clinic.

1.21.4Scope

This guideline relates to all insert name HHS employees, contractors and consultants and all organisations and individuals acting as its agents for Queensland Health.

1.31.5Supporting documents

The overarching documentAuthorising Policyand Standard/sis the:

Queensland Health pandemic influenza plan

Supporting documents include: Procedures, Guidelines and Protocols:

oOutreach clinic checklist (insert hyperlink)

guidelines for the administration of pandemic (H1N1) influenza vaccine from multi- dose vialsguidelines for the administration of pandemic (H1N1) influenza vaccine from multi- dose vials(

mMulti dose vial training programiLearn training module (under review(insert hyperlink here))

Related documents:

Disaster Management Act 2003

Health (Drugs and Poisons) Regulation 1996

Public Health Act 2005

Health Act 1937

Australian Immunisation Handbook – current edition

Australian Health Management Plan for Pandemic Influenza((draft, under developmentinsert hyperlink)2014 to be updated)

National Vaccine Storage Guidelines - Strive for 5 (2nd ed)

1.51.6Objectives

To have in place accessible service points for mass vaccination of all eligible people within the HHS in accordance with the Australian Health Management Plan for Pandemic Influenza (AHMPPI) (2013.)

Monitor and report on any adverse events associated with vaccine(s)

1.61.7Assumptions

The arrangements detailed in this plan are based on the following operational assumptions:

  • aA standardised Incident Management System will be in place in Queensland Health
  • dDemand for pandemic vaccine may surpass immediate availability.
  • dDetermining the priority groups to receive initial doses of both candidate and customised pandemic vaccine will be established by the Australian Government
  • vVaccine(s) are expected to be provided in multi-dose vials
  • vVaccine(s) may need to be administered in two doses. The second dose will not be administered before recommended minimum time intervals which will be determined once the vaccine has been developed
  • tThere will be a need to increase health service capacity to staff mMass vVaccination cClinics. This could be achieved by sourcing staff from within the HHS as well as sourcing staff that are not currently employed by Queensland Health.
  1. Activation

Within insert name HHS, the insert role, has the authority to activate the establishment of mass vaccination clinics.

  1. Command, control and coordination

The command, control and coordination arrangements are consistent with the Queensland Health Disaster Plan. (2013a).

The Incident Management Team within insert nameHHS sits within the Health Emergency Operation Centre (HEOC) and controls the resources, decisions and coordination of all emergency and response activities within insert nameHHS.

Activation

Within insert name HHS, the insert role, has the authority to activate the establishment of mass vaccination clinic(s).

2.1Management within a mass vaccination clinic

Within the mass vaccination clinic the insert rolewill be responsible for reporting to the medical sector commanderoperations officer (or delegate) within the HEOC. Consideration should be given to the most appropriate and reliable form of communication for local conditions.

2.2Roles and responsibilities

Roles and responsibilities of the Queensland Health Immunisation Program (QHIP) are:

to coordinate the National Immunisation Program (NIP) in Qld

coordinate and communicate with the Commonwealth

order vaccine from producing pharmaceutical company

coordinate storage and distribution of pandemic vaccines (and if required consumable material supplied nationally) to existing vaccine service providers

receive orders for vaccine from providers

monitor reported Adverse Events Following Immunisation (AEFI).

Roles and responsibilities of HHSs are to:

continue to deliver NIP (Australian Department of Health 2014)

ensure compliance with the current edition of the Australian Immunisation Handbook, the National Vaccine Storage Guidelines and the Health (Drugs and Poisons) Regulation 1996

provide mass vaccination programs as required (Queensland Government 2013a)

ensure adequate storage for vaccines and consumables

identify individuals at risk that would be most likely to benefit from immunisations based on national strategy (Australian Department of Health 2014)

report immunisation data to the local public health unit (Queensland Government 2013b).

report and follow up adverse events following immunisation (Queensland Government 2013a)

provide community education on the seasonal and pandemic immunisation program (Australian Department of Health 2014)

notify Queensland Ambulance Service when planning a large vaccination clinic that is additional to existing services.

Refer to the AHMPPI (insert hyperlink) for further guidance on the roles and responsibilities on a national, state and health sector level regarding pandemic preparedness and response activities in relation to mass vaccination programs.

Roles and responsibilities

Refer to the AHMPPI (2014) for guidance on the roles and responsibilities on a national, state and health sector level regarding pandemic preparedness and response activities in relation to mass vaccination programs.

Queensland Health Immunisation Program’s (QHIP) roles and responsibilities are:

To coordinate the National Immunisation Program (NIP) in QLD

Coordinate and communicate with Comonwealth

Order vaccine from producing pharmaceutical company

Coordinate storage and distribution of pandemic vaccines (and if required consumable material supplied nationally) to existing vaccine service providers

Receive orders for vaccine from providers

Coordinate and communicate with Commonwealth

Monitor reported adverse events following immunisation

HHS roles and responsibilities are to

Continue to deliver NIP (AHMPPI, 2014)

Comply with the National Health and Medical Research Council guidelines, the current edition of the , the and the (Qld). (Queensland Government, 2013a)

Provide mass vaccination programs as required (Queensland Government, 2013a)

Ensure adequate storage for vaccines and consumables

Identify individuals at risk that would be most likely to benefit from immunisations based on national strategy (AHMPPI, 2014)

Report immunisation data to the local public health unit (Queensland Government, 2013b)

Report and follow up adverse events following immunisation (Queensland Government, 2013a)

Provide community education on the seasonal and pandemic immunisation program, led by local public health units [GPs, culturally and linguistically diverse community groups, Aboriginal and Torres Strait Islander health sector]. (AHMPPI, 2014)

Notify Queensland Ambulance Service when planning an large immunisation clinic that is additional to existing services

  1. Concept of operations
  2. Site selection

The selection and acquisition of sites is being coordinated by insert role. This includes the development of formal agreements if required.

Within insert name HHS, final authorisation of any arrangements is the responsibility of insert name

Concept of operations

Site selection

The selection and acquisition of sites is being coordinated by insert role. This includes the development of formal agreements if required.

The final HHS authorisation of any arrangements is the responsibility of insert name

HHS Pprimary mass vaccination clinic

The primary mass vaccination clinic in insert name insert name HHS will could be located at insert name of facility.

The model(s) for mass vaccination is/arebriefly describe model. eg. community based clinic, mobile clinic.

Additional mass vaccination clinics

Additional mass vaccination clinics in insert name HHS could be located at insert name of facility.

The model(s) for mass vaccination is/are briefly describe model. eg. community based clinic, mobile clinic.

Secondary mass vaccination clinics will be established at insert place.

3.2The model(s) for mass vaccination is briefly describe modelAt risk groups.

High risk groups

Aboriginal and Torres Strait Islander peoples

Based on seasonal influenza and experiences from past pandemics the AHMPPI has identified Aboriginal and Torres Strait Islander peoples as a potential at risk group and consequently specific strategies to mitigate risk are required (Australian Department of Health 2014).

In addition to the primary MVC mass vaccination clinic within insert nameHHS,a vaccination clinic specifically targeted towards Aboriginal and Torres Strait Islander peoples will also be able to be vaccinated atavailable atindicate where specific alternative vaccination program will be available.

Staff vaccination

Mass vaccination of health care workers with pandemic vaccine should build on the processes in place for existing workforce immunisation programs. Please refer to Queensland Health Guideline: Vaccination of Healthcare Workers for further guidance.

The staff vaccination clinic in insert name HHS will be located at insert name of location.

3.3Support to non-Queensland Hhealth vaccine service providers

In insert nameHHS, support will be given to non-Queensland Health VSP’s vaccine service providers insert name eg. AICCHS, GP, RFDSinsert name eg. AMS, GP, RFDS to facilitate operate mass vaccination clinics.

Describe how support will be provided

3.4Human resources

Training

In insert name HHS clinical staff working within the mass vaccination clinic will be provided with specific training on describe content eg. vaccine use, storage, etc.

Training will be provided by insert name / position and will consist of describe training model eg. online, workshop etc.

3.5Vaccine

To maintain the delivery of the NIP in Queensland, QHIP supply vaccines under the National Partnership Agreement on Essential Vaccines and also via state contracts with pharmaceutical manufacturing companies.

In an influenza pandemic, when a suitable vaccine virus has been endorsed for use in Australia, this existing arrangement will be scaled up to ensure pandemic vaccine supply to Queensland.

Complete Appendix 1 to estimate staffing requirements.

Training

In insert name HHS clinical staff working within the MVC will be provided with specific training on describe content eg. vaccine use, storage, etc.

Training will be provided by insert name / position and will consist of describe training model eg. online, workshop etc.

Vaccine

QHIP supply vaccine both under the NPAEV agreement with the Commonwealth and statemaintains contracts with pharmaceutical manufacturing companies to maintain the delivery of the NIP in QLD. In the event of a pandemic influenza, when a suitable vaccine virus has been endorsed for use in Australia, this existing arrangement will be scaled up to ensure pandemic vaccine supply to QLD.

Administration of vaccine

All vaccines must be administered in accordance with the relevant legislation, andthe current version of the Australian Immunisation Handbook (Australian Government Department of Health and Ageing 2013a) (2013) and national recommendations for administration of a pandemic vaccine in consultation with the state and locally based expert groups.

Cold chain

All vaccines must be monitored and maintained at appropriate cold chain temperatures as per the National Vaccine Storage Guidelines – Strive for 5 (Australian Government Department of Health and Ageing 2013b). (2013).

Multi-dose vials

Multidose vials are not routinely used in Australia however where mass vaccination of the population is required multidose vials have some advantages over single-dose vaccines (Australian Government Department of Health and Ageing 2013a). Multidose vials provide for the availability of a vaccine substantially earlier than single dose or pre-filled syringes as the time it takes for the manufacturer to fill and finish the vaccine is significantly reduced in comparison to single doses (Australian Government Department of Health and Ageing 2011). This allows for more vaccine to be available for use in a shorter period of time.Multi-dose vials are not routinely used in Australia (Australian Technical Advisory Group on Immunisation, no date). In a pandemic situation the vaccine may be presented in multi dose vials as doing so significantly reduces the time it takes for the manufacturer to fill and finishproduce the vaccine compared to single doses. This would allow more the quantity of vaccine required to be available for use in a shorter period of time (Commonwealth of Australia, 2011). Please refer to the guideline for the administration of pandemic influenza vaccine from multi-dose vials and the multi-dose vial vaccine training packageiLearn module(under developmentinsert hyperlink) for instructions on appropriate use.

Estimate of amount of vaccine required

The Australian Government will determine the priority groups to receive initial doses of both candidate and customised pandemic vaccine. Once this has occurred, HHSs will be required to order vaccines from QHIP for their MVCsmass vaccination clinics. Refer to QHEP Vaccine request form for further information.

Adverse events following immunisation

An adverse event following immunisation (AEFI) is any untoward medical occurrence that follows immunisation and does not necessarily have a causal relationship with the usage of the vaccine (Australian Immunisation HandbookNHMRC 2013). In Queensland, AEFI are notifiable using the aAdverse eEvent fFollowing iImmunisation rReporting fForm.

3.4Anaphylaxis following vaccination is rare but can be fatal. All immunisation service providers must be able to recognise all the symptoms and signs of anaphylaxis and distinguish between anaphylaxis, convulsions and fainting. An anaphylaxis response kit must be on hand whenever vaccines are given. Refer to the Australian Immunisation Handbook for information on preparing an anaphylaxis response kit (Australian Government Department of Health and Ageing 2013).

3.53.6Monitoring strategy

National operational surveillance guidelines will be provided by the Australian Department of Health.Await surveillance plan to identify the processes for Queensland Health vaccine service providers to record and report details of vaccine doses administered so as to meet Commonwealth and Queensland Health reporting requirements

Clarify if a patient health record that specifies date of administration and first dose and a reminder of when to return is a second dose is required. And if so will it be developed by the National Government or State?

4.Review

This Guideline is due for review on: DD-MM-YYYY

Date of last review: DD-MM-YYYY

Supersedes: insert the name of the superseded guideline

Business area contact

Insert the name of the business area contact

5.Definitions of terms used in the policy and supporting documents

[Copy the Definitions of terms from the Policy here and include any additional terms relating specifically to this Guideline]

Term / Definition / Explanation / Details / Source

6.Approval and implementation

Policy Custodian:

Insert the position of the officer (SO or above) who will have responsibility for implementation of the document